In order to determine the cell signaling pathways mediating the thioridazine-induced tumor inhibition in the 4T1 breast cancer cells, the levels of Akt, STAT3 and NFκB p65 were analyzed. This evidence concerns the gene NFKB1 and breast carcinoma.